Health Care & Life Sciences » Pharmaceuticals | Apeloa Pharmaceutical Co. Ltd.

Apeloa Pharmaceutical Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
813
810
795
553
551
745
Total Accounts Receivable
815
888
904
1,285
1,485
1,300
Inventories
632
585
722
693
727
901
Other Current Assets
138
53
44
110
107
128
Total Current Assets
2,398
2,335
2,465
2,641
2,870
3,075
Net Property, Plant & Equipment
1,759
2,176
2,325
2,342
2,292
2,127
Total Investments and Advances
-
1
30
32
36
101
Intangible Assets
491
508
504
471
431
393
Other Assets
-
1
12
65
7
15
Total Assets
4,676
5,062
5,395
5,619
5,691
5,751
ST Debt & Current Portion LT Debt
1,692
1,471
1,660
1,456
1,359
Accounts Payable
624
627
706
812
663
Income Tax Payable
42
32
40
76
68
Other Current Liabilities
218
357
276
305
348
Total Current Liabilities
2,575
2,487
2,682
2,649
2,437
Long-Term Debt
167
172
197
180
-
Deferred Taxes
27
40
58
66
54
Other Liabilities
-
-
-
72
72
Total Liabilities
2,743
2,660
2,879
2,902
2,511
Common Equity (Total)
1,792
2,306
2,417
2,616
3,050
Total Shareholders' Equity
1,792
2,306
2,417
2,616
3,050
Total Equity
1,858
2,306
2,417
2,616
3,050
Liabilities & Shareholders' Equity
4,676
5,062
5,395
5,619
5,691
Accumulated Minority Interest
-
65
-
-
-
Non-Equity Reserves
75
95
99
101
130

About Apeloa Pharmaceutical Co.

View Profile
Address
No. 333 Hengdianjiang South Road
Dongyang Zhejiang 322118
China
Employees -
Website http://www.apeloa.com
Updated 07/08/2019
Apeloa Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients, and drug preparation. Its products include levofloxacin hydrochloride, amantadine hydrochloride, ofloxacin, adamantane, and other pharmaceutical ingredients. It also offers capsules, ointment, granules, and injections.